Does Insurance Coverage For Drug Therapy Affect Smoking Cessation?
- 1 November 2002
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 21 (6) , 162-168
- https://doi.org/10.1377/hlthaff.21.6.162
Abstract
Whether insurance coverage for smoking-cessation medicines increases quitting rates is uncertain. In this paper we evaluate the overall effect of a new health plan pharmacy benefit on the use of pharmacotherapy, attempts to quit, and quitting rates. The presence of a smoking-cessation pharmacy benefit as implemented by these health plans produced no change in the use of bupropion, nicotine patches, or nicotine gum, nor did it result in higher rates of quitting smoking. Further studies are needed to test whether greater efforts to make smokers aware of insurance benefits or adding other types of cessation support might lead to any beneficial effects.Keywords
This publication has 6 references indexed in Scilit:
- Variations in treatment benefits influence smoking cessation: results of a randomised controlled trialTobacco Control, 2001
- Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessationNicotine & Tobacco Research, 2001
- Results from the first annual survey on Addressing Tobacco in Managed CareTobacco Control, 1998
- Public health benefit of over-the-counter nicotine medicationsTobacco Control, 1997
- Web Watch: tracking tobacco on the InternetTobacco Control, 1997
- Effect of cost on the self-administration and efficacy of nicotine gum: A preliminary studyPreventive Medicine, 1991